Comparison of the 12-Month Outcomes of Intravitreal Ranibizumab between Two Angiographic Subtypes of Polypoidal Choroidal Vasculopathy

Publisher： Karger

E-ISSN： 1423-0267|237|3|123-127

ISSN： 0030-3755

Source： Ophthalmologica, Vol.237, Iss.3, 2017-03, pp. : 123-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the Outcomes of Photodynamic Therapy between Two Angiographic Subtypes of Polypoidal Choroidal Vasculopathy

By  

Ophthalmologica, Vol. 232, Iss. 2, 2014-06 ,pp. : 92-96

Karger

Access to resources Recommend Favorite

Comparison of the Effectiveness and Prognostic Factors of Intravitreal Ranibizumab between Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy over 24 Months of Follow-Up

By  

Ophthalmologica, Vol. 234, Iss. 1, 2015-06 ,pp. : 33-39

Karger

Access to resources Recommend Favorite

The Association of Age-related Maculopathy Susceptibility 2 (ARMS2) and Complement Factor H (CFH) Variants with Two Angiographic Subtypes of Polypoidal Choroidal Vasculopathy

By Miki Akiko   Honda Shigeru   Kondo Naoshi   Negi Akira  

Ophthalmic Genetics, Vol. 34, Iss. 3, 2013-09 ,pp. : 146-150

Informa Healthcare

Access to resources Recommend Favorite

One-Year Results of Intravitreal Ranibizumab with or without Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

By  

Ophthalmologica, Vol. 226, Iss. 3, 2011-07 ,pp. : 119-126

Karger

Access to resources Recommend Favorite

Long-Term Follow-Up of Polypoidal Choroidal Vasculopathy Secondary to Angioid Streaks Treated by Intravitreal Aflibercept and Ranibizumab

By  

Case Reports in Ophthalmology, Vol. 8, Iss. 1, 2017-04 ,pp. : 221-231

Karger

Access to resources Recommend Favorite